A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers

Clinical trial NCT06345001 · COMPLETED

Trial details

NCT number: NCT06345001
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma (HCC)Solid Tumors

Start date: 2024-08-26
Primary completion: 2025-03-10
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.